GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

adenylosuccinate synthase 2

Gene

synaptotagmin 12

Gene

HHLA1 neighbor of OC90

Gene

polypeptide N-acetylgalactosaminyltransferase 5

Gene

potassium voltage-gated channel subfamily Q member 5

Gene

SEC14 and spectrin domain containing 1

Gene

vascular endothelial zinc finger 1

Gene

GAR1 ribonucleoprotein

Gene

ribosomal protein L6

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    adenylosuccinate synthase 2


  • Gene

    synaptotagmin 12


  • Gene

    HHLA1 neighbor of OC90


  • Gene

    polypeptide N-acetylgalactosaminyltransferase 5


  • Gene

    potassium voltage-gated channel subfamily Q member 5


  • Gene

    SEC14 and spectrin domain containing 1


  • Gene

    vascular endothelial zinc finger 1


  • Gene

    GAR1 ribonucleoprotein


  • Gene

    ribosomal protein L6

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.